*To the Editor*:

The effect of maternal smoking during pregnancy on child lung function during the first months of life is an old concern ([@bib1]). Serious consequences range from sudden infant death syndrome to asthma ([@bib2], [@bib3]). McEvoy and colleagues' randomized controlled trial showing that adding daily supplemental vitamin C for pregnant smokers improves their infant's newborn pulmonary function may be a step forward, but it deserved questions ([@bib4]).

First, did these pregnant smokers fail to quit smoking despite proactive treatment for cessation by a trained multidisciplinary team? Smoking cessation may be the most important health intervention during pregnancy because smoking is the most preventable cause of preterm birth and all other complications during pregnancies except hypertensive pregnancy. Proactive treatment means motivational interview and psychological support plus nicotine replacement therapy. The former is a prerequisite for the effectiveness of the latter because smokers need reassurance first. Indeed, tobacco is the worst addictive product: all smokers have made serial attempts to quit, almost always failing with much pain, and further smoking increases the odds of depressive symptoms. The latter must combine patches with faster-acting forms (lozenge or spray) of nicotine replacement therapy. This "belt and braces" strategy has been shown to double the odds ratio of quitting during pregnancy. Sadly, this proactive treatment is poorly implemented despite being robustly evidence based ([@bib5]).

Second, did these pregnant smokers receive at least nicotine replacement therapy during the trial, and at what dose? Indeed, it is less dangerous to smoke with patches than without, as it decreases not only the number of cigarettes but also the puff volumes. Although the precautionary principle and experimental findings pledge for avoiding nicotine per second during pregnancy ([@bib6]), the issue for pregnant smokers and their unborn child is different, being about harm/benefit ratio. The main problems are carbon monoxide (which has strong affinity for fetal hemoglobin), tar, and hundreds of extremely toxic combustion byproducts. Moreover, the devastating effects of compensatory uptake (deeper puffs with higher temperature) when trying to reduce tobacco use without nicotine substitutes cannot be overlooked. Considering the very high urine cotinine level in the trial ([@bib1]), this compensatory uptake seems most likely. Could McEvoy and colleagues provide data about the carbon monoxide breath test?
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